A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.

from News-Medical.Net Weight Loss News Feed http://ift.tt/1QqPOYW
Follow Us on Twitter
Follow Us on FB
Follow Us on Pinterest
Follow Us on G+
Follow Us on Instagram
Follow Us on Instagram
Follow Us on Delicious
Follow Us on Wordpress